432D image
Deposition Date 1998-10-14
Release Date 1999-12-18
Last Version Date 2024-04-03
Entry Detail
PDB ID:
432D
Keywords:
Title:
D(GGCCAATTGG) COMPLEXED WITH DAPI
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.89 Å
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*GP*GP*CP*CP*AP*AP*TP*TP*GP*G)-3')
Chain IDs:A, B
Chain Length:10
Number of Molecules:2
Biological Source:
Ligand Molecules
Primary Citation
Crystal structure of d(GGCCAATTGG) complexed with DAPI reveals novel binding mode.
Biochemistry 38 16443 16451 (1999)
PMID: 10600105 DOI: 10.1021/bi9907882

Abstact

The single-crystal X-ray structure of the complex between the minor groove binder 4',6-diamidino-2-phenylindole (DAPI) and d(GGCCAATTGG) reveals a novel way of off-centered binding, with an unique hydrogen bond between the minor groove binder and a CG base pair. Application of crystal engineering and cryocooling techniques helped to extend the resolution to 1.9 A, resulting in an unambiguous determination of drug conformation and orientation. The structure was refined to completion using SHELXL-93, resulting in a residual factor R of 18. 0% for 3562 reflections with F(o) > 4sigma(F(o)) including 81 water molecules. As the bulky NH(2)-group on guanine is believed to prevent drug binding in the minor groove, the nature and stability of the CG-DAPI contact was further addressed in full detail using ab initio quantum chemical methods. The amino groups involved in the guanine-drug interaction are substantially nonplanar, resulting in an energy gain of about 5 kcal/mol. The combined structural and theoretical data suggest that the guanine NH(2)-group does not destabilize the drug binding to an extent that it prevents complexation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures